img

Global Durvalumab Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Durvalumab Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Durvalumab report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Durvalumab market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Locally Advanced Urothelial Carcinoma and Metastatic Urothelial Carcinoma are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Durvalumab industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Durvalumab key manufacturers include Medimmune (AstraZeneca). etc. Medimmune (AstraZeneca), , are top 3 players and held % sales share in total in 2022.
Durvalumab can be divided into 2.4mL Injection and 10mL Injection, etc. 2.4mL Injection is the mainstream product in the market, accounting for % sales share globally in 2022.
Durvalumab is widely used in various fields, such as Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma and Other,, etc. Locally Advanced Urothelial Carcinoma provides greatest supports to the Durvalumab industry development. In 2022, global % sales of Durvalumab went into Locally Advanced Urothelial Carcinoma filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Durvalumab market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Medimmune (AstraZeneca)
Segment by Type
2.4mL Injection
10mL Injection

Segment by Application


Locally Advanced Urothelial Carcinoma
Metastatic Urothelial Carcinoma
Other

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Durvalumab market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Durvalumab, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Durvalumab industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Durvalumab in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Durvalumab introduction, etc. Durvalumab Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Durvalumab market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Durvalumab Market Overview
1.1 Durvalumab Product Overview
1.2 Durvalumab Market Segment by Type
1.2.1 2.4mL Injection
1.2.2 10mL Injection
1.3 Global Durvalumab Market Size by Type
1.3.1 Global Durvalumab Market Size Overview by Type (2018-2034)
1.3.2 Global Durvalumab Historic Market Size Review by Type (2018-2024)
1.3.3 Global Durvalumab Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Durvalumab Sales Breakdown by Type (2018-2024)
1.4.2 Europe Durvalumab Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Durvalumab Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Durvalumab Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Durvalumab Sales Breakdown by Type (2018-2024)
2 Global Durvalumab Market Competition by Company
2.1 Global Top Players by Durvalumab Sales (2018-2024)
2.2 Global Top Players by Durvalumab Revenue (2018-2024)
2.3 Global Top Players by Durvalumab Price (2018-2024)
2.4 Global Top Manufacturers Durvalumab Manufacturing Base Distribution, Sales Area, Product Type
2.5 Durvalumab Market Competitive Situation and Trends
2.5.1 Durvalumab Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Durvalumab Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Durvalumab as of 2022)
2.7 Date of Key Manufacturers Enter into Durvalumab Market
2.8 Key Manufacturers Durvalumab Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Durvalumab Status and Outlook by Region
3.1 Global Durvalumab Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Durvalumab Historic Market Size by Region
3.2.1 Global Durvalumab Sales in Volume by Region (2018-2024)
3.2.2 Global Durvalumab Sales in Value by Region (2018-2024)
3.2.3 Global Durvalumab Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Durvalumab Forecasted Market Size by Region
3.3.1 Global Durvalumab Sales in Volume by Region (2024-2034)
3.3.2 Global Durvalumab Sales in Value by Region (2024-2034)
3.3.3 Global Durvalumab Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Durvalumab by Application
4.1 Durvalumab Market Segment by Application
4.1.1 Locally Advanced Urothelial Carcinoma
4.1.2 Metastatic Urothelial Carcinoma
4.1.3 Other
4.2 Global Durvalumab Market Size by Application
4.2.1 Global Durvalumab Market Size Overview by Application (2018-2034)
4.2.2 Global Durvalumab Historic Market Size Review by Application (2018-2024)
4.2.3 Global Durvalumab Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Durvalumab Sales Breakdown by Application (2018-2024)
4.3.2 Europe Durvalumab Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Durvalumab Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Durvalumab Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Durvalumab Sales Breakdown by Application (2018-2024)
5 North America Durvalumab by Country
5.1 North America Durvalumab Historic Market Size by Country
5.1.1 North America Durvalumab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Durvalumab Sales in Volume by Country (2018-2024)
5.1.3 North America Durvalumab Sales in Value by Country (2018-2024)
5.2 North America Durvalumab Forecasted Market Size by Country
5.2.1 North America Durvalumab Sales in Volume by Country (2024-2034)
5.2.2 North America Durvalumab Sales in Value by Country (2024-2034)
6 Europe Durvalumab by Country
6.1 Europe Durvalumab Historic Market Size by Country
6.1.1 Europe Durvalumab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Durvalumab Sales in Volume by Country (2018-2024)
6.1.3 Europe Durvalumab Sales in Value by Country (2018-2024)
6.2 Europe Durvalumab Forecasted Market Size by Country
6.2.1 Europe Durvalumab Sales in Volume by Country (2024-2034)
6.2.2 Europe Durvalumab Sales in Value by Country (2024-2034)
7 Asia-Pacific Durvalumab by Region
7.1 Asia-Pacific Durvalumab Historic Market Size by Region
7.1.1 Asia-Pacific Durvalumab Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Durvalumab Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Durvalumab Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Durvalumab Forecasted Market Size by Region
7.2.1 Asia-Pacific Durvalumab Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Durvalumab Sales in Value by Region (2024-2034)
8 Latin America Durvalumab by Country
8.1 Latin America Durvalumab Historic Market Size by Country
8.1.1 Latin America Durvalumab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Durvalumab Sales in Volume by Country (2018-2024)
8.1.3 Latin America Durvalumab Sales in Value by Country (2018-2024)
8.2 Latin America Durvalumab Forecasted Market Size by Country
8.2.1 Latin America Durvalumab Sales in Volume by Country (2024-2034)
8.2.2 Latin America Durvalumab Sales in Value by Country (2024-2034)
9 Middle East and Africa Durvalumab by Country
9.1 Middle East and Africa Durvalumab Historic Market Size by Country
9.1.1 Middle East and Africa Durvalumab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Durvalumab Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Durvalumab Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Durvalumab Forecasted Market Size by Country
9.2.1 Middle East and Africa Durvalumab Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Durvalumab Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Medimmune (AstraZeneca)
10.1.1 Medimmune (AstraZeneca) Company Information
10.1.2 Medimmune (AstraZeneca) Introduction and Business Overview
10.1.3 Medimmune (AstraZeneca) Durvalumab Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Medimmune (AstraZeneca) Durvalumab Products Offered
10.1.5 Medimmune (AstraZeneca) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Durvalumab Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Durvalumab Industrial Chain Analysis
11.4 Durvalumab Market Dynamics
11.4.1 Durvalumab Industry Trends
11.4.2 Durvalumab Market Drivers
11.4.3 Durvalumab Market Challenges
11.4.4 Durvalumab Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Durvalumab Distributors
12.3 Durvalumab Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 2.4mL Injection
Table 2. Major Company of 10mL Injection
Table 3. Global Durvalumab Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Durvalumab Sales by Type (2018-2024) & (K Pcs)
Table 5. Global Durvalumab Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Durvalumab Sales by Type (2018-2024) & (US& Million)
Table 7. Global Durvalumab Market Share in Value by Type (2018-2024)
Table 8. Global Durvalumab Price by Type (2018-2024) & (USD/Pcs)
Table 9. Global Durvalumab Sales by Type (2024-2034) & (K Pcs)
Table 10. Global Durvalumab Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Durvalumab Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Durvalumab Sales Market Share in Value by Type (2024-2034)
Table 13. Global Durvalumab Price by Type (2024-2034) & (USD/Pcs)
Table 14. North America Durvalumab Sales by Type (2018-2024) & (K Pcs)
Table 15. North America Durvalumab Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Durvalumab Sales (K Pcs) by Type (2018-2024)
Table 17. Europe Durvalumab Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Durvalumab Sales (K Pcs) by Type (2018-2024)
Table 19. Asia-Pacific Durvalumab Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Durvalumab Sales (K Pcs) by Type (2018-2024)
Table 21. Latin America Durvalumab Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Durvalumab Sales (K Pcs) by Type (2018-2024)
Table 23. Middle East and Africa Durvalumab Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Durvalumab Sales by Company (2018-2024) & (K Pcs)
Table 25. Global Durvalumab Sales Share by Company (2018-2024)
Table 26. Global Durvalumab Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Durvalumab Revenue Share by Company (2018-2024)
Table 28. Global Market Durvalumab Price by Company (2018-2024) & (USD/Pcs)
Table 29. Global Durvalumab Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Durvalumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Durvalumab as of 2022)
Table 32. Date of Key Manufacturers Enter into Durvalumab Market
Table 33. Key Manufacturers Durvalumab Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Durvalumab Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Durvalumab Sales by Region (2018-2024) & (K Pcs)
Table 37. Global Durvalumab Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Durvalumab Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Durvalumab Sales Market Share in Value by Region (2018-2024)
Table 40. Global Durvalumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 41. Global Durvalumab Sales by Region (2024-2034) & (K Pcs)
Table 42. Global Durvalumab Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Durvalumab Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Durvalumab Sales Market Share in Value by Region (2024-2034)
Table 45. Global Durvalumab Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 46. Global Durvalumab Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Durvalumab Sales by Application (2018-2024) & (K Pcs)
Table 48. Global Durvalumab Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Durvalumab Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Durvalumab Sales Market Share in Value by Application (2018-2024)
Table 51. Global Durvalumab Price by Application (2018-2024) & (USD/Pcs)
Table 52. Global Durvalumab Sales by Application (2024-2034) & (K Pcs)
Table 53. Global Durvalumab Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Durvalumab Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Durvalumab Sales Market Share in Value by Application (2024-2034)
Table 56. Global Durvalumab Price by Application (2024-2034) & (USD/Pcs)
Table 57. North America Durvalumab Sales by Application (2018-2024) (K Pcs)
Table 58. North America Durvalumab Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Durvalumab Sales by Application (2018-2024) (K Pcs)
Table 60. Europe Durvalumab Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Durvalumab Sales by Application (2018-2024) (K Pcs)
Table 62. Asia-Pacific Durvalumab Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Durvalumab Sales by Application (2018-2024) (K Pcs)
Table 64. Latin America Durvalumab Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Durvalumab Sales by Application (2018-2024) (K Pcs)
Table 66. Middle East and Africa Durvalumab Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Durvalumab Sales by Country (2018-2024) & (K Pcs)
Table 68. North America Durvalumab Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Durvalumab Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Durvalumab Sales Market Share in Value by Country (2018-2024)
Table 71. North America Durvalumab Sales by Country (2024-2034) & (K Pcs)
Table 72. North America Durvalumab Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Durvalumab Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Durvalumab Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Durvalumab Sales by Country (2018-2024) & (K Pcs)
Table 76. Europe Durvalumab Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Durvalumab Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Durvalumab Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Durvalumab Sales by Country (2024-2034) & (K Pcs)
Table 80. Europe Durvalumab Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Durvalumab Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Durvalumab Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Durvalumab Sales by Region (2018-2024) & (K Pcs)
Table 84. Asia-Pacific Durvalumab Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Durvalumab Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Durvalumab Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Durvalumab Sales by Region (2024-2034) & (K Pcs)
Table 88. Asia-Pacific Durvalumab Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Durvalumab Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Durvalumab Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Durvalumab Sales by Country (2018-2024) & (K Pcs)
Table 92. Latin America Durvalumab Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Durvalumab Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Durvalumab Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Durvalumab Sales by Country (2024-2034) & (K Pcs)
Table 96. Latin America Durvalumab Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Durvalumab Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Durvalumab Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Durvalumab Sales by Country (2018-2024) & (K Pcs)
Table 100. Middle East and Africa Durvalumab Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Durvalumab Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Durvalumab Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Durvalumab Sales by Country (2024-2034) & (K Pcs)
Table 104. Middle East and Africa Durvalumab Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Durvalumab Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Durvalumab Sales Market Share in Value by Country (2024-2034)
Table 107. Medimmune (AstraZeneca) Company Information
Table 108. Medimmune (AstraZeneca) Introduction and Business Overview
Table 109. Medimmune (AstraZeneca) Durvalumab Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 110. Medimmune (AstraZeneca) Durvalumab Product
Table 111. Medimmune (AstraZeneca) Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Durvalumab Market Trends
Table 115. Durvalumab Market Drivers
Table 116. Durvalumab Market Challenges
Table 117. Durvalumab Market Restraints
Table 118. Durvalumab Distributors List
Table 119. Durvalumab Downstream Customers
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Durvalumab Product Picture
Figure 2. Global Durvalumab Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Durvalumab Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Durvalumab Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of 2.4mL Injection
Figure 6. Global 2.4mL Injection Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of 10mL Injection
Figure 8. Global 10mL Injection Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Global Durvalumab Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Durvalumab Sales Market Share by Type in 2022 & 2034
Figure 11. North America Durvalumab Sales Market Share in Volume by Type in 2022
Figure 12. North America Durvalumab Sales Market Share in Value by Type in 2022
Figure 13. Europe Durvalumab Sales Market Share in Volume by Type in 2022
Figure 14. Europe Durvalumab Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Durvalumab Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Durvalumab Sales Market Share in Value by Type in 2022
Figure 17. Latin America Durvalumab Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Durvalumab Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Durvalumab Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Durvalumab Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Durvalumab Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Durvalumab Revenue in 2022
Figure 23. Durvalumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Locally Advanced Urothelial Carcinoma
Figure 25. Global Locally Advanced Urothelial Carcinoma Sales YoY Growth (2018-2034) & (K Pcs)
Figure 26. Product Picture of Metastatic Urothelial Carcinoma
Figure 27. Global Metastatic Urothelial Carcinoma Sales YoY Growth (2018-2034) & (K Pcs)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2018-2034) & (K Pcs)
Figure 30. Global Durvalumab Sales by Application (2018-2034) & (US$ Million)
Figure 31. Global Durvalumab Sales Market Share by Application in 2022 & 2034
Figure 32. North America Durvalumab Sales Market Share in Volume by Application in 2022
Figure 33. North America Durvalumab Sales Market Share in Value by Application in 2022
Figure 34. Europe Durvalumab Sales Market Share in Volume by Application in 2022
Figure 35. Europe Durvalumab Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Durvalumab Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Durvalumab Sales Market Share in Value by Application in 2022
Figure 38. Latin America Durvalumab Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Durvalumab Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Durvalumab Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Durvalumab Manufacturing Cost Structure
Figure 43. Durvalumab Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed